BIS vs. OZEM ETF Comparison
Comparison of ProShares UltraShort Nasdaq Biotechnology (BIS) to Roundhill GLP-1 & Weight Loss ETF (OZEM)
BIS
ProShares UltraShort Nasdaq Biotechnology
BIS Description
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
Grade (RS Rating)
Last Trade
$16.67
Average Daily Volume
13,744
73
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.Grade (RS Rating)
Last Trade
$25.91
Average Daily Volume
37,536
14
Performance
| Period | BIS | OZEM |
|---|---|---|
| 30 Days | 7.34% | -7.33% |
| 60 Days | 11.36% | -7.73% |
| 90 Days | 16.52% | -10.10% |
| 12 Months | -28.39% |
BIS Overweight 71 Positions Relative to OZEM
| Symbol | Grade | Weight | |
|---|---|---|---|
| GILD | C | 7.41% | |
| VRTX | F | 7.21% | |
| BIIB | F | 6.12% | |
| ILMN | D | 5.67% | |
| INCY | C | 2.09% | |
| BMRN | D | 1.91% | |
| ALNY | D | 1.6% | |
| VTRS | A | 1.35% | |
| SNY | F | 1.29% | |
| NBIX | C | 1.16% | |
| SRPT | D | 1.15% | |
| NVCR | C | 1.1% | |
| JAZZ | B | 1.03% | |
| TECH | D | 1.02% | |
| IONS | F | 1.02% | |
| GH | B | 0.96% | |
| AMRN | F | 0.85% | |
| MRNA | F | 0.83% | |
| BGNE | D | 0.83% | |
| ACAD | D | 0.81% | |
| ASND | D | 0.77% | |
| EXEL | B | 0.73% | |
| ARWR | F | 0.65% | |
| BLUE | F | 0.65% | |
| BBIO | F | 0.51% | |
| ALLK | D | 0.49% | |
| UTHR | C | 0.49% | |
| NKTR | F | 0.48% | |
| SAGE | F | 0.48% | |
| BPMC | C | 0.48% | |
| FGEN | D | 0.47% | |
| AGIO | C | 0.43% | |
| CRSP | D | 0.42% | |
| RARE | D | 0.42% | |
| ADPT | C | 0.42% | |
| MEDP | D | 0.4% | |
| PTCT | B | 0.4% | |
| ARGX | A | 0.4% | |
| AXSM | B | 0.38% | |
| ALLO | F | 0.37% | |
| GRFS | C | 0.36% | |
| IOVA | F | 0.36% | |
| ALKS | B | 0.36% | |
| KOD | C | 0.35% | |
| HALO | F | 0.35% | |
| QURE | D | 0.35% | |
| FOLD | F | 0.32% | |
| APLS | D | 0.31% | |
| XNCR | B | 0.26% | |
| MYGN | F | 0.26% | |
| DNLI | D | 0.26% | |
| ZLAB | C | 0.24% | |
| IRWD | F | 0.24% | |
| ARVN | D | 0.24% | |
| INSM | C | 0.23% | |
| FATE | F | 0.23% | |
| PCRX | C | 0.22% | |
| GLPG | D | 0.22% | |
| ITCI | C | 0.21% | |
| RGNX | F | 0.21% | |
| ESPR | C | 0.19% | |
| EDIT | F | 0.19% | |
| LGND | B | 0.19% | |
| INVA | D | 0.18% | |
| VCYT | B | 0.18% | |
| ALEC | F | 0.18% | |
| TBPH | C | 0.17% | |
| YMAB | F | 0.16% | |
| CHRS | D | 0.16% | |
| HCM | D | 0.15% | |
| SUPN | C | 0.15% |
BIS: Top Represented Industries & Keywords
OZEM: Top Represented Industries & Keywords
Compare ETFs
